XML 51 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Incentive Plan (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

 

 

 

2016 Plan

 

 

2019 Plan

 

 

 

Year Ended

December 31, 2020

 

 

Year Ended

December 31, 2019

 

 

Year Ended

December 31, 2020

 

 

Year Ended

December 31, 2019

 

Total fair value of stock options granted

 

$

-

 

 

$

2,492

 

 

$

9,241

 

 

$

974

 

Total fair value of options vested

 

 

-

 

 

 

1,439

 

 

 

2,711

 

 

 

-

 

Summary of Valuation Models of Fair Value of Awards Granted To Employees and Non-Employees Under 2016 Plan The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non-employees under both the 2019 Plan and the 2016 Plan:

 

 

 

Year Ended

December 31, 2020

 

 

Year Ended

December 31, 2019

 

Expected volatility

 

37.63 - 41.24%

 

 

36.92 - 37.70%

 

Expected term (in years)

 

 

6.0

 

 

6 - 6.5

 

Dividend yield

 

0%

 

 

0%

 

Risk free interest rate

 

0.30 - 1.43%

 

 

1.79 - 2.89%

 

Stock Based Compensation Expense Included In Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

 

 

 

December 31,

 

 

 

2020

 

 

2019

 

Cost of revenues

 

$

1,336

 

 

$

573

 

General and administrative

 

 

1,198

 

 

 

1,161

 

Research and development

 

 

268

 

 

 

87

 

Sales and marketing

 

 

633

 

 

 

444

 

Total

 

$

3,435

 

 

$

2,265

 

Restricted Stock Units [Member]  
Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity under the 2019 Plan:

 

 

RSUs

 

Description

 

Outstanding

 

Outstanding at December 31, 2019

 

 

-

 

Granted

 

 

1,402,312

 

Forfeited

 

 

(111,880

)

Expired

 

 

-

 

Outstanding at December 31, 2020

 

 

1,290,432

 

 

2019 Plan [Member]  
Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity under the 2019 Plan:

 

Description

 

Options

Outstanding

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value (1)

 

Options outstanding, December 31, 2018

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

514,710

 

 

$

9.90

 

 

 

10.0

 

 

 

 

 

Forfeited

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding, December 31, 2019

 

 

514,710

 

 

$

9.90

 

 

 

10.0

 

 

 

 

 

Granted

 

 

4,137,750

 

 

 

8.49

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(387,186

)

 

 

8.85

 

 

 

 

 

 

 

 

 

Expired

 

 

(4,521

)

 

 

8.85

 

 

 

 

 

 

 

 

 

Options outstanding, December 31, 2020

 

 

4,260,753

 

 

$

8.46

 

 

 

9.0

 

 

$

54

 

Options vested and exercisable, December 31, 2020

 

 

1,204,863

 

 

$

8.20

 

 

 

9.0

 

 

$

54

 

Options vested and expected to vest, December 31, 2020

 

 

4,260,753

 

 

$

8.46

 

 

 

9.0

 

 

$

54

 

2016 Plan [Member]  
Schedule of Stock Option Activity

 

The following table summarizes the Company’s stock option activity under the 2016 Plan:

 

Description

 

Options

Outstanding

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value (1)

 

Options Outstanding, December 31, 2018

 

 

411,480

 

 

$

100

 

 

 

8.3

 

 

$

 

Granted

 

 

67,050

 

 

 

90

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(32,860

)

 

 

99

 

 

 

 

 

 

 

 

 

Expired

 

 

(8,640

)

 

 

99

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(437,030

)

 

 

100

 

 

 

 

 

 

 

 

 

Options Outstanding, December 31, 2019

 

 

-

 

 

 

 

 

 

 

 

 

 

$

 

 

(1)

Aggregate intrinsic value (in thousands) represents the difference between the estimated fair value of the underlying common stock and the exercise price of outstanding, in-the-money options.